http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-122020025103-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd3f2b1421bade0e7904cbda6efdfe6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C275-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-78
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
filingDate 2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb7cfb2446d55cd14f00128efabddcb
publicationDate 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-122020025103-B1
titleOfInvention COMPOUNDS, AND PHARMACEUTICAL COMPOSITION OR DRUG COMPRISING THEM
abstract The present invention relates to compounds which are useful as potassium channel openers, in particular as Kv7.4 potassium channel openers. The compounds are compounds according to formula (I), wherein - n = 0 or 1, - RL is a substituent selected from the group consisting of substituted or unsubstituted cycloalkyl groups, in particular bicycloalkyl groups, phenyl groups substituted or unsubstituted thienyl groups, substituted or unsubstituted thienyl groups or cyclopentathienyl groups, and substituted or unsubstituted indanyl groups, which optionally contain heteroatoms, and RR is a substituent selected from the group consisting of substituted or unsubstituted phenyl groups or benzyl groups substituted or unsubstituted, which optionally contain heteroatoms, or a stereoisomer, a tautomer, a prodrug or a salt, preferably a pharmaceutically acceptable salt thereof.
priorityDate 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672301
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453116950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416742796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423357187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430213144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456462261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51944492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430200234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135319254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135309177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448863010
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311068

Total number of triples: 70.